Givaudan reported CHF9.23M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Air Liquide EUR 577.57M 2.6B Dec/2025
Akzo Nobel EUR 171.41M 100K Jun/2026
Anheuser-Busch USD 1.95B 0 Jun/2026
Arkema EUR 75.61M 56K Jun/2026
Associated British Foods GBP 716M 11.34M Dec/2025
BASF EUR 884.32M 8.2M Jun/2026
Bayer EUR 982.42M 0 Mar/2026
Beiersdorf EUR 218.92M 1.29M Dec/2025
British American Tobacco GBP 2.17B 14.14M Jun/2026
Covestro EUR 207.64M 18.9M Dec/2025
Croda International GBP 139.64M 124.54M Jun/2025
Danone EUR 642.12M 1.94M Jun/2026
Diageo GBP 2.23B 4.43M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Givaudan CHF 9.23M 0 Dec/2025
Heineken EUR 560.56M 4.31M Dec/2025
Henkel EUR 406.79M 7.18M Dec/2025
International Flavors Fragrances USD 255.3M 100K Jun/2026
Johnson Matthey GBP 168.06M 0 Jun/2026
Kerry EUR 158.93M 138.13M Jun/2026
Lonza CHF 68.64M 0 Dec/2025
L'Oréal EUR 532.39M 1.4M Jun/2026
Merck EUR 434.78M 0 Mar/2026
Nestle CHF 2.57B 0 Jun/2026
Pernod Ricard EUR 251.67M 81.98K Dec/2025
Reckitt Benckiser GBP 679.21M 605.21M Jun/2025
SGS CHF 193.57M 185.57M Jun/2025
Sika AG CHF 160.44M 5.27K Dec/2025
Solvay EUR 104.62M 145K Jun/2026
Tate & Lyle GBP 445.45M 0 Jun/2026
Umicore EUR 240.56M 1.14B Dec/2025
Victrex GBP 87.12M 71.6K Jun/2026